摘要: Rumors about a potential new phase of the Pfizer/AstraZeneca takeover saga just won't go away, with all the talk giving the U.K. pharma's share price a lift this week. And while analysts have been abu ...
| Rumors about a potential new phase of the Pfizer/AstraZeneca takeover saga just won't go away, with all the talk giving the U.K. pharma's share price a lift this week. And while analysts have been abuzz with the possibilities of a backup bid for Actavis ($ACT) or even GlaxoSmithKline ($GSK), AZ ($AZN) seems to remain the coveted megamerger/tax inversion target that could have the impact Pfizer ($PFE) needs. |
我们提供专业的服务， 从产品定位、机械的生产制造，我们 实力出众，只因我们更努力
公司生产的生物反应器及各种配套设备，可替代国外同类产品的垄断，并帮助企业节省生产成本，同时提供生产过程中各种技术支持。
我们一如既往地根据用户的需求、市场环境、企业状况等进行综合分析并提供真实可靠的解决方案，迄今为止服务上千家企业。
我们将致力于优质的技术服务确保每个机械设备的安全，用更成熟的方案解决每一个问题，为企业提供一站式服务。
